Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

13C- Pyruvate DNP Hyperpolarised Magnetic Resonance Imaging Metabolic Assessment of Disease

NCT03687645 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03687645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03687645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
13C- Pyruvate DNP Hyperpolarised Magnetic Resonance Imaging Metabolic Assessment of Disease
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2017
Completion date
June 30, 2020
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cardiovascular diseases